InsidersTradesSigma
Follow the 君实生物 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 君实生物 has published 2 public disclosures. Market capitalisation: €36.8bn. The latest transaction was disclosed on 31 March 2026 (Purchase). Among the most active insiders: 熊俊. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
君实生物 is a company focused on the healthcare and pharmaceutical sector, dedicated to the research and development of innovative treatments. It is listed on the XSHG market.